Elanix Biotechnologies AG Logo

Elanix Biotechnologies AG

ELN | F

Overview

Corporate Details

ISIN(s):
DE000A0WMJQ4
LEI:
391200SYNFFL0NPAJK90
Country:
Germany
Address:
Hanauer Landstrasse 291, 60314 Frankfurt am Main
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and gynecological applications, as well as providing cell technology services. The company was founded in 2012 as a spin-off from the University Hospital of Lausanne (CHUV), Switzerland, to commercialize a patented progenitor cell technology. Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix owns GMP certified Master and Working cell banks containing vast quantities of cells. The Company is headquartered in Epalinges, Switzerland with offices in Hamburg and listed on the Frankfurt stock exchange under the symbol ELN.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Elanix Biotechnologies AG and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2023-02-14 10:05
Board/Management Information
Elanix Biotechnologies AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD
English 5.1 KB
2022-12-21 18:30
Major Shareholding Notification
German 4.6 KB
2022-12-19 12:30
Declaration of Voting Results & Voting Rights Announcements
German 14.0 KB
2022-12-06 13:00
Declaration of Voting Results & Voting Rights Announcements
German 14.2 KB
2022-12-05 10:15
Declaration of Voting Results & Voting Rights Announcements
German 13.7 KB
2022-12-02 15:15
Declaration of Voting Results & Voting Rights Announcements
German 14.0 KB
2020-02-27 12:19
Board/Management Information
ELANIX BIOTECHNOLOGIES AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD …
English 4.8 KB
2019-10-03 10:34
Report Publication Announcement
English 2.0 KB
2019-08-21 16:49
Report Publication Announcement
English 2.0 KB
2019-08-19 16:58
Report Publication Announcement
English 2.0 KB
2019-07-26 13:51
Declaration of Voting Results & Voting Rights Announcements
English 14.0 KB
2019-07-23 16:59
Declaration of Voting Results & Voting Rights Announcements
English 14.0 KB
2019-07-22 10:17
Declaration of Voting Results & Voting Rights Announcements
English 14.0 KB
2019-06-25 14:03
Declaration of Voting Results & Voting Rights Announcements
English 13.9 KB
2019-06-25 13:57
Major Shareholding Notification
English 13.9 KB

Automate Your Workflow. Get a real-time feed of all Elanix Biotechnologies AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Elanix Biotechnologies AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
RYVU Therapeutics S.A. Logo
Clinical-stage drug discovery company developing novel small molecule therapies for oncology.
Poland RVU
Saniona Logo
Biopharma developing medicines for epilepsy and neurological disorders using ion channel research.
Denmark SANION
SAREUM HOLDINGS PLC Logo
Clinical-stage developer of kinase inhibitors for autoimmune disease & cancer.
United Kingdom SAR
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom SCLP
Scandion Oncology A/S Logo
A liquidated biotech that developed oral drugs to overcome cancer treatment resistance.
Denmark SCOL
SCIENCE GROUP PLC Logo
International science & tech consultancy providing advisory, R&D, and product development.
United Kingdom SAG
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland SLV
Sensorion Logo
Clinical-stage biotech developing novel therapies for hearing loss, vertigo, and tinnitus.
France ALSEN
Simris Group AB Logo
Develops novel cyanobacteria-based payloads for Antibody-Drug Conjugates to treat cancer.
Sweden SIMRIS
SKINBIOTHERAPEUTICS PLC Logo
A life science company developing microbiome-based skin health products and supplements.
United Kingdom SBTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.